Schizophrenia.com

Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression

https://www.globenewswire.com/news-release/2021/02/22/2179539/0/en/Intra-Cellular-Therapies-Applies-for-FDA-Approval-of-CAPLYTA-lumateperone-for-the-Treatment-of-Bipolar-Depression.html

3 Likes